Alpha Tau Medical (DRTS) Fundamentals 2026 — Revenue Analysis | SniperIQ
Alpha Tau Medical (DRTS) is a IL-listed Healthcare company in Medical - Equipment & Services with a market capitalization of
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Alpha Tau Medical's market cap?
Alpha Tau Medical (DRTS) has a market capitalization of approximately
What is Alpha Tau Medical's P/E ratio?
Alpha Tau Medical's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 16.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Alpha Tau Medical?
Alpha Tau Medical runs a net profit margin of 0.0%, a gross margin of 0.0%, and an operating margin of 0.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Does Alpha Tau Medical pay a dividend?
Alpha Tau Medical does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Alpha Tau Medical financially healthy?
Alpha Tau Medical carries a debt-to-equity ratio of 0.21x and a current ratio of 7.79x, with a market beta of 1.17. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Alpha Tau Medical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Alpha Tau Medical (DRTS) the key facts are: market cap
Track Alpha Tau Medical's full fundamentals live
Get Alpha Tau Medical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.